Anhui Hanbon Daily Chemical Co., Ltd. – FDA 483, Feb 28, 2025
An FDA inspection of Anhui Hanbon Daily Chemical Co., Ltd., an OTC manufacturer in Huainan, China, revealed significant deficiencies across its quality system, production, and laboratory controls. The firm failed to establish and follow adequate procedures for annual product reviews, process controls, test method validation, raw material identity testing, and stability studies. Additionally, laboratory equipment was not properly qualified or calibrated, indicating a severe lack of control over drug product quality.
ID · 563c7b1b-18c9-4420-85ea-342a1a0cc4f8
Full citation text and observation details available on the Dashboard.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.